Headlines Search
SEGMENT GROUP SUBGROUP FILINGS

Healthcare

http://news1.equities.com/2013/01/30/983286.html

Research from Hokkaido University Hospital Provides New Insights into Nuclear Engineering

Nuclear EngineeringNewsRx.com

By a News Reporter-Staff News Editor at Biotech Week -- Researchers detail new data in Nuclear Engineering. According to news reporting originating in Hokkaido, Japan, by NewsRx journalists, research stated, "We report the usefulness of F-18-FDG PET/CT for the detection and therapy evaluation of the infective vegetation. A 64-year-old man with history of aortic valve replacement presented with 2 months of fever without identifiable cause."

The news reporters obtained a quote from the research from Hokkaido University Hospital, "Echocardiogram showed no inflammation vegetation or abnormality of mechanical valve function. FDG PET/CT with 50 IU/kg IV heparin revealed focal uptakes near the mechanical aortic valve. After antibiotics therapy, fever was ameliorated, and FDG PET/CT findings showed markedly decreased uptake of the lesions."

According to the news reporters, the research concluded: "FDG PET/CT is a powerful tool to detect endocarditis even in patients with no anatomical abnormalities."

For more information on this research see: Cardiac F-18-FDG PET/CT With Heparin Detects Infective Vegetation in a Patient With Mechanical Valve Replacement. Clinical Nuclear Medicine, 2012;37(12):1184-1185. Clinical Nuclear Medicine can be contacted at: Lippincott Williams & Wilkins, 530 Walnut St, Philadelphia, PA 19106-3621, USA (see also Nuclear Engineering).

Our news correspondents report that additional information may be obtained by contacting A. Klaipetch, Hokkaido Univ Hosp, Dept. of Cardiovasc Med, Sapporo, Hokkaido 0608638, Japan.

Keywords for this news article include: Asia, Japan, Heparin, Therapy, Hokkaido, Cardiology, Nuclear Engineering

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2013, NewsRx LLC






Top Video News